{"lastClose": 5.789999961853027, "len": 1109, "date": "2023-03-09", "alpha_1": -0.27496846263388175, "beta_1": 1.6683462337889887, "drawup_1": 1.5486725887776869, "natr_1": 14.8025504233765, "res_1": 0.41738630096523144, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 29.981371378733744, "adx_1": 26.21294908090356, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.18650590755110677, "stratHoldAlpha_1": 250.8703781212977, "stratHoldDrawdown_1": -0.6385542379122888, "alpha_3mo": -0.0378868075404144, "beta_3mo": 1.911651526512336, "drawup_3mo": 0.4608541290620036, "natr_3mo": 14.8025504233765, "sup_3mo": -0.0696602816606013, "res_3mo": 0.19055843204301795, "bullPattern_3mo": [], "bearPattern_3mo": ["CLOSINGMARUBOZU", "ENGULFING", "LONGLINE"], "rsi_3mo": 22.52250800957799, "adx_3mo": 25.972983218331414, "drawdown_3mo": -0.30186338479501984, "stratHoldSharpe_3mo": -1.7787942171773317, "stratHoldAlpha_3mo": 249.93369408862256, "stratHoldDrawdown_3mo": -0.2716770463155179, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "Market Cap": 840745198, "sup_1": -0.2740357087071236, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "alpha%_1": 0.23512423004464467, "beta%_1": 0.9125001203151233, "drawup%_1": 0.9972736241183556, "natr%_1": 0.9999968994097307, "drawdown%_1": 0.06030440118847459, "stratHoldSharpe%_1": 0.3656768000026881, "stratHoldAlpha%_1": 0.27624295219313866, "stratHoldDrawdown%_1": 0.0470151593812044, "alpha%_3mo": 0.26454630670326923, "beta%_3mo": 0.951795046106399, "drawup%_3mo": 0.8935404730835579, "natr%_3mo": 0.9999959429907265, "drawdown%_3mo": 0.04040372945696246, "stratHoldSharpe%_3mo": 0.11090994359477929, "stratHoldAlpha%_3mo": 0.018142769775011645, "stratHoldDrawdown%_3mo": 0.04503697781594763}